A detailed history of Fora Capital, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 12,290 shares of EBS stock, worth $123,268. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,290
Holding current value
$123,268
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.72 - $14.77 $70,298 - $181,523
12,290 New
12,290 $102,000
Q4 2020

Feb 12, 2021

SELL
$79.17 - $111.47 $199,112 - $280,347
-2,515 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$81.91 - $134.94 $206,003 - $339,374
2,515 New
2,515 $260 Million
Q2 2020

Aug 14, 2020

SELL
$54.33 - $89.52 $89,481 - $147,439
-1,647 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$49.34 - $68.76 $81,262 - $113,247
1,647 New
1,647 $95,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $500M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.